Patients (n = 2 400) from 27 Dutch lipid clinics were enrolled in the study when diagnosed with FH, based on either the presence of a low-density lipoprotein receptor mutation or strict clinical criteria. The gene discussed is VLDLR; the disease is familial hyperaldosteronism.